Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouse
- PMID: 163905
- DOI: 10.1530/jrf.0.0420251
Prolonged antioestrogenic activity of ICI 46, 474 in the ovariectomized mouse
Abstract
Subcutaneous administration of ICI 46,474 (3 mg) to ovariectomized mice was found to produce vaginal refractoriness to subcutaneously administered oestradiol for up to 6 weeks. Tritiated oestradiol-17 beta accumulated in the uterus and vagina of the ovariectomized mouse, with maximum accumulation at 3 to 4 hr. This property of the target tissues was used to investigate the binding of tritiated oestradiol after the administration of 3 mg ICI 46,474 to ovariectomized mice. Radioactivity in the vagina was found to be comparable to control values 6 weeks after ICI 46,474 administration; uterine levels of radioactivity returned to control values by 10 weeks. Administration of ICI 46,474 had an oestrogenic effect upon the mouse uterus whereas the vagina appeared to be initially stimulated and was then unable to respond to or to bind oestradiol.
Similar articles
-
Inhibition of oestradiol binding to mouse uterine and vaginal oestrogen receptors by triphenylethylenes.J Endocrinol. 1975 Jan;64(1):193-4. doi: 10.1677/joe.0.0640193. J Endocrinol. 1975. PMID: 163879 No abstract available.
-
Effect on reproductive organs of three clomiphene analogues.Br J Pharmacol. 1972 Oct;46(2):324-8. doi: 10.1111/j.1476-5381.1972.tb06877.x. Br J Pharmacol. 1972. PMID: 4651775 Free PMC article.
-
Effects of oestrogen antagonists on mitosis and (3H)oestradiol binding in the mouse uterus.J Endocrinol. 1974 Jan;60(1):167-74. doi: 10.1677/joe.0.0600167. J Endocrinol. 1974. PMID: 4359943 No abstract available.
-
Anti-oestrogenic activity in compounds related to ethamoxytriphetol (MER 25), clomiphene and MRL 37.Br J Pharmacol. 1973 Jun;48(2):345P. Br J Pharmacol. 1973. PMID: 4733745 Free PMC article. No abstract available.
-
Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.J Endocrinol. 1991 Sep;130(3):409-14. doi: 10.1677/joe.0.1300409. J Endocrinol. 1991. PMID: 1834757
Cited by
-
Nuclear receptors and their selective pharmacologic modulators.Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23457206 Free PMC article. Review.
-
Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.Drugs. 1978 Jul;16(1):1-24. doi: 10.2165/00003495-197816010-00001. Drugs. 1978. PMID: 352663 Review.
-
Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.Breast Cancer Res Treat. 1982;2(2):123-38. doi: 10.1007/BF01806449. Breast Cancer Res Treat. 1982. PMID: 6184101 Review.
-
Structure-activity relationships of estrogens.Environ Health Perspect. 1985 Sep;61:97-110. doi: 10.1289/ehp.856197. Environ Health Perspect. 1985. PMID: 3905383 Free PMC article. Review.
-
Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.Cancer Drug Resist. 2021;4(4):762-783. doi: 10.20517/cdr.2021.33. Epub 2021 Jul 8. Cancer Drug Resist. 2021. PMID: 34532657 Free PMC article.